Spice drugs: cannabinoids as a new designer drugs

被引:37
|
作者
Mustata, Cristina [1 ,2 ]
Torrens, Marta [1 ,3 ]
Pardo, Ricardo [1 ,2 ]
Perez, Clara [1 ,2 ]
Farre, Magi [1 ,2 ]
机构
[1] Hosp del Mar, IMIM, Unidad Farmacol Humana & Neurociencias, Programa Neuropsicofarmacol, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Hosp del Mar, IMIM, Unidad Toxicomanias, Inst Atencio Psiquiatr Salut Mental & Toxicomanie, Barcelona 08003, Spain
关键词
Spice drugs; synthetic cannabinoids designer drugs; JWH-018; CP; 47497; JWH-073; HU-210; RECEPTORS; CB1; CLASSIFICATION; PHARMACOLOGY; ANANDAMIDE; AGONISTS;
D O I
10.20882/adicciones.227
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Some smokable herbal mixtures under the brand name Spice drugs have been sold on the Internet and in specialised shops (smart shops) since 2004. The mixtures are advertised as an exotic incense blend which releases a rich aroma and not for human consumption. When smoked, Spice drugs products have been reported by some users to have effects similar to those of cannabis. Spice drugs have received intensive attention in drug forums due to the possibility to obtain a non legal substitute of cannabis. Forensic analyses have found different potent synthetic cannabinoid agonists in some Spice drugs products, as JWH-018, CP 47497, JWH-073 and HU-210. There are few data about its pharmacological properties in animals, but nothing about its toxicity. At present, almost nothing is known about the pharmacology, toxicology and safety profile of such compounds in humans, except the opinions of consumers in internet forums. Neither the herbal ingredients of Spice drugs, nor any of the synthetic cannabinoids found in them, are internationally controlled under the 1961 or 1971 UN drug control conventions. Some European countries have recently taken legal actions to ban or otherwise control Spice drugs products and related compounds. These cannabinoid substances can be considered as new products to be added to the list of "designer drugs".
引用
收藏
页码:181 / 186
页数:6
相关论文
共 50 条
  • [21] LC AND LC-MS/MS METHODS FOR SYNTHETIC CANNABINOIDS IN NOVEL "SPICE" DRUGS
    Feng, Zhai W.
    Shui, Zhang C.
    Sheng, Gao L.
    FORENSIC SCIENCE INTERNATIONAL, 2017, 277 : 191 - 191
  • [22] TRANSCRIPTION FACTORS - TARGETS FOR NEW DESIGNER DRUGS
    BUSTIN, SA
    MCKAY, IA
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 1994, 51 (02) : 147 - 157
  • [23] Designer drugs: New directed therapies for cancer
    Feig, SA
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 281 - 283
  • [24] Designer steroids: new drugs of abuse in sport
    Catlin, D. H. C.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 : 24 - 24
  • [25] The evolving high: New designer drugs of abuse
    Pourmand, A.
    Armstrong, P.
    Mazer-Amirshahi, M.
    Shokoohi, H.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2014, 33 (10) : 993 - 999
  • [26] Designer drugs: New directed therapies for cancer
    Stephen A. Feig
    International Journal of Hematology, 2002, 76 : 281 - 283
  • [27] Cannabinoids and antiepileptic drugs
    Czuczwar, Stanislaw J.
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 332 - 333
  • [28] Cannabinoids as orphan drugs
    Klotz, Kerstin Alexandra
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (04): : 286 - 291
  • [29] DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs
    Ogata, Jun
    Uchiyama, Nahoko
    Kikura-Hanajiri, Ruri
    Goda, Yukihiro
    FORENSIC SCIENCE INTERNATIONAL, 2013, 227 (1-3) : 33 - 41
  • [30] DESIGNER DRUGS Deaths associated with new designer drug 5-IT
    Seetohul, L. Nitin
    Maskell, Peter D.
    De Paoli, Giorgia
    Pounder, Derrick J.
    BRITISH MEDICAL JOURNAL, 2012, 345